+201203140000
Joseph & Levine 71 suggested that activity in signaling pathways that ultimately lead to apoptosis plays a critical role in the generation of neuropathic pain, before death of sensory neurones becomes apparent. Activator and effector caspases, defining components of programmed cell death signalling pathways, also contribute to pain-related behaviour in animals with small fibre peripheral neuropathies. The death receptor ligand, tumour necrosis factor α, and its https://ecosoberhouse.com/ downstream second messenger, ceramide, also produce pain-related behaviour via this mechanism. This suggests that these pathways are potential targets for novel pharmacological agents for the treatment of inflammatory as well as neuropathic pain 71. Four studies addressed the management of patients with alcohol-related peripheral neuropathy. These studies addressed abstinence from alcohol consumption and administration of vitamins.
How long it takes for alcoholic neuropathy to develop depends on many factors, including the amount of daily alcohol drug addiction consumed, a person’s age and overall health, their nutritional intake, and other individual factors. But in most cases, alcoholic neuropathy takes several years or even decades to develop, depending on the amount of alcohol consumed. There are no medications that can help improve loss of sensation, strengthen muscle weakness, or assist with the coordination and balance problems caused by alcoholic neuropathy.
A deficiency of vitamin B1 in chronic alcoholics can be due to inadequate dietary intake, reduced capacity for hepatic storage, inhibition of intestinal transport and absorption or decreased formation of the active coenzyme form. In an animal study, it has been found that chronic alcohol consumption in rats resulted in a significant depletion in thiamine diphosphate (TDP), the active coenzyme form of thiamine. Supplementation with benfotiamine significantly increased concentrations of TDP and total thiamine compared with supplementation with thiamine HCl 96. An 8 week, randomized, multicentre, placebo-controlled, double-blind study compared the effect of benfotiamine alone with a benfotiamine complex (Milgamma-N) or placebo in 84 alcoholic patients. Parameters measured included vibration perception in the great toe, ankle and tibia, neural pain intensity, motor function and paralysis, sensory function and overall neuropathy score and clinical assessment. Although benfotiamine therapy was superior to Milgamma-N or placebo for all parameters, results reached statistical significance only for motor function, paralysis and overall neuropathy score.
The subgroup without thiamine deficiency consisted of 36 patients, while the subgroup with thiamine deficiency consisted of 28 patients. In addition, 32 patients with nonalcoholic thiamine deficiency neuropathy were also evaluated for comparison. The subgroup without thiamine deficiency, considered to be a pure form of alcoholic neuropathy, uniformly showed slowly progressive, sensory dominant symptoms. Superficial sensation, especially nociception, was predominantly impaired and painful symptoms were the primary complaint in most patients in this group. The histologic features of sural nerve biopsy specimens demonstrated small fibre predominant axonal loss as characteristic of the pure form of alcoholic neuropathy. Clinical features of alcoholic peripheral neuropathy develop slowly, extending over a period of months and include abnormalities in sensory, motor, autonomic and gait functions.
The damage may affect the autonomic nerves (those that regulate internal body functions) and the nerves that control movement and sensation. N-acetylcysteine, an amino acid, is a potent antioxidant and helps to enhance glutathione concentrations. N-acetylcysteine may have application in the prevention or treatment of neuropathy. Rats with experimentally-induced diabetes for 2 months had a 20% reduction in nerve conduction velocity and 48% reduction in endoneurial blood flow. A mechanism of cisplatin chemotherapy-induced peripheral neuropathy was elucidated in an in vitro mouse model. Apoptosis of neurones was induced by cisplatin, but pre-incubation with N-acetylcysteine completely blocked apoptosis 112.
Indeed, these factors contribute to the progression of ALN symptoms; however, they do not constitute direct factors that manifest in ALN development 84. Current postulation holds that dysfunctions within the central and peripheral nervous system are due to both direct and indirect toxic effects of alcohol 31, 85,86,87. Indirect effects are mainly induced by vitamin deficiencies (B1, B2, B3, B5, B6, B7, B9, and B12) 84, 88. In general, the nerves in lower limbs were more affected than the upper limbs 3, 37–39. Four studies reported abnormalities only in sensory nerves 33, 47, 63, 64, while ten reported abnormalities in both sensory and alcoholic neuropathy motor nerves 2–4, 16, 38, 54, 56, 58, 59, 65.
The prevalence of alcoholic cardiomyopathy appears to be similar among males and females; however, males present a higher disease burden 132, 133. Furthermore, females tend to be more vulnerable to the brain damage and neurotoxic effects of alcohol 134. Computed tomography (CT) scans showed that among alcohol-dependent patients, the brain volumes were reduced to increase the volume of cerebrospinal fluid; these changes were induced in females in less time 135, 136. The mouse model of the injection of β-estradiol in males resulted in higher activity of cytosolic alcohol dehydrogenase (ADH), microsomal aniline hydroxylase (ANH), and aldehyde dehydrogenase (ALDH) which are crucial in ethanol metabolism 138.
Thus, in alcoholics with the mutated dehydrogenase enzyme, acetaldehyde concentrations may reach values about 20 times higher than in individuals without the mutation. A certain amount of acetaldehyde is not metabolized by the usual pathways (Figure 2) and binds irreversibly to proteins which results in the creation of cytotoxic proteins which adversely affect the function of nervous system cells. These abnormal proteins influence other cell populations especially the hepatocytes where the damage to hepatic mitochondria results in hepatic cirrhosis with reduction of energetic substrates in the liver. The action of these abnormal proteins is explained by competition with normal proteins causing the damage to function and metabolism of the cell 22.